MoneyWeek

News

San Jose

Elizabeth Holmes (pictured), the founder of Theranos, the bogus biotech start-up she created in 2003 aged 19, has been convicted of four counts of fraudulently deceiving investors. A date for sentencing has yet to be set, but each charge carries a prison term of up to 20 years. Holmes was acquitted on four charges of deceiving patients and doctors. Theranos was based around a “radical advance in blood-testing technology” that Holmes hoped would allow hundreds of tests to be performed using a tiny drop of blood rather than a vial, says The Economist. Otherwise, the company differed little from many start-ups. It raised $1bn, and was at one point valued at $9bn, before it disintegrated “into a vast graveyard of unfeasible ideas”. The prosecution argued Holmes had exaggerated potential sales to investors and trumpeted endorsements from the armed forces and big pharma that did not

You’re reading a preview, subscribe to read more.

More from MoneyWeek

MoneyWeek2 min read
I Wish I Knew What The Magnificent Seven Were, But I’m Too Embarrassed To Ask
The Magnificent Seven is a nickname for the group of companies that has been responsible for much of the gains in the US stockmarket over the past year or so. The term became popular after Bank of America analyst Michael Hartnett used it in a researc
MoneyWeek3 min read
Glimmers Of Hope?
Our columns have been full of doom and gloom recently about the prospects for the US economy. But is there not a glimmer of hope? Isn’t Javier Milei turning Argentina around? Didn’t Greece pull out of its crisis successfully? Or consider the case of
MoneyWeek1 min read
Wine Of The Week: The Finest Rosé This Season
Rosé season has well and truly kicked off, and here is a selection of the very finest so far this year. The 2023 L’Exuberance Rosé du Clos Cantenac (£19.75, privatecellar.co.uk) is a delicate flower with an enchanting cranberry, rose petal and sour-c

Related Books & Audiobooks